Debanjan Ray is CFO at CytomX Therapeutics, Inc. (CTMX). They have made 14 open-market trades across 1 company since 2017, most recently 2018-12-12.
CIK 0001706863
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CTMX | 5,928 | $14K |
Shares reported on the most recent Form 4, priced at the 2018-12-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CTMX | SELL · 10b5-1 | 2018-12-12 | 2018-12-14 | $15.00 | $45K | -0.3% | +13.3% | -29.6% |
| CTMX | SELL · 10b5-1 | 2018-11-01 | 2018-11-05 | $15.00 | $45K | +0.9% | -1.3% | +36.2% |
| CTMX | SELL | 2018-10-01 | 2018-10-02 | $18.46 | $55K | -12.5% | -18.3% | -16.3% |
| CTMX | SELL | 2018-09-04 | 2018-09-06 | $22.39 | $67K | -6.3% | -18.2% | -31.3% |
| CTMX | SELL | 2018-08-01 | 2018-08-02 | $26.05 | $78K | -12.5% | -13.8% | -44.7% |
| CTMX | SELL | 2018-07-02 | 2018-07-03 | $22.56 | $68K | -7.0% | +2.6% | -25.5% |
| CTMX | SELL | 2018-06-01 | 2018-06-05 | $25.93 | $78K | +12.5% | +12.7% | +0.3% |
| CTMX | SELL | 2018-05-01 | 2018-05-02 | $26.52 | $80K | -11.9% | -3.6% | -0.5% |
| CTMX | SELL | 2018-04-02 | 2018-04-04 | $28.12 | $84K | -7.9% | -15.5% | -15.7% |
| CTMX | SELL | 2018-03-02 | 2018-03-05 | $30.37 | $607K | +4.4% | -10.0% | -34.5% |
| CTMX | SELL | 2018-03-01 | 2018-03-05 | $29.40 | $382K | +4.4% | -10.0% | -34.5% |
| CTMX | SELL | 2018-03-01 | 2018-03-05 | $30.13 | $1.6M | +4.4% | -10.0% | -34.5% |
| CTMX | SELL | 2018-02-01 | 2018-02-02 | $26.69 | $136K | +5.5% | +22.9% | -6.3% |
| CTMX | SELL | 2018-01-02 | 2018-01-03 | $21.11 | $53K | +10.0% | +19.3% | +23.7% |
| CTMX | SELL | 2017-12-01 | 2017-12-05 | $20.58 | $103K | +5.0% | +11.3% | +58.9% |
| CTMX | SELL | 2017-11-01 | 2017-11-03 | $20.00 | $50K | -1.4% | +2.6% | +35.1% |
| CTMX | SELL · 10b5-1 | 2017-10-02 | 2017-10-04 | $18.10 | $45K | -9.8% | -11.0% | -4.2% |
| CTMX | SELL · 10b5-1 | 2017-09-01 | 2017-09-05 | $17.17 | $43K | +2.1% | +30.1% | +22.7% |
| CTMX | SELL · 10b5-1 | 2017-08-09 | 2017-08-11 | $15.00 | $38K | +9.2% | +23.1% | +37.5% |
| CTMX | SELL · 10b5-1 | 2017-07-03 | 2017-07-06 | $15.47 | $39K | -8.2% | -14.0% | +45.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.